Ubigene Biosciences

Ubigene Biosciences is a contract research organization specializing in CRISPR-based gene editing services for academic and industry partners worldwide. The company offers a comprehensive portfolio of gene editing solutions including:

Core Services:

• EZ-editor™ Editing Cell Lines: precision knockout, knockin, and point mutation cell lines
• EZ-OE™ Stable Cell Line technology for precise DNA integration and high-expression without viral methods
• CRISPR-iScreen™ library screening with plasmid, virus, and cell pool options
• Functional screening and NGS analysis services
• iPSC gene editing for regenerative medicine applications

Products & Tools:

• Red Cotton OmniCell Bank: 8,000+ ready-to-use cell lines (KO, wild-type, Cas9 stable, reporter lines, stem cells)
• CRISPR Gene Editing Designer: automated tool for designing three gene-editing strategies in one minute
• iScreenAnlys™: CRISPR library automated analysis platform
• EZ-editor™ Gene Assessment Systems (dependency, expression, copy number, genotype analysis)

Capabilities: The company supports gene function studies, cancer research, gene therapy development, and other research applications. Services include 1-week expedited delivery for standard knockout cell lines and customized 4-week projects. Global reach with presence across multiple countries and partnerships with academic institutions and industry leaders.